LOXL2 Recombinant Antibody, Biotin Conjugated, Rabbit

Catalog Number: BSS-BSM-54163R-BIOTIN
Article Name: LOXL2 Recombinant Antibody, Biotin Conjugated, Rabbit
Biozol Catalog Number: BSS-BSM-54163R-BIOTIN
Supplier Catalog Number: bsm-54163R-Biotin
Alternative Catalog Number: BSS-BSM-54163R-BIOTIN-100
Manufacturer: Bioss
Host: Rabbit
Category: Antikörper
Application: WB
Species Reactivity: Human
Conjugation: Biotin
Alternative Names: Lysyl oxidase homolog 2, Lysyl oxidase-like protein 2, Lysyl oxidase-related protein 2, Lysyl oxidase-related protein WS9-14, LOXL2,
Mediates the post-translational oxidative deamination of lysine residues on target proteins leading to the formation of deaminated lysine (allysine). When secreted in the extracellular matrix, promotes cross-linking of extracellular matrix proteins by mediating oxidative deamination of peptidyl lysine residues in precursors to fibrous collagen and elastin. Acts as a regulator of sprouting angiogenesis, probably via collagen IV scaffolding. When nuclear, acts as a transcription corepressor and specifically mediates deamination of trimethylated Lys-4 of histone H3 (H3K4me3), a specific tag for epigenetic transcriptional activation. Involved in epithelial to mesenchymal transition (EMT) via interaction with SNAI1 and participates in repression of E-cadherin, probably by mediating deamination of histone H3. Also involved in E-cadherin repression following hypoxia, a hallmark of epithelial to mesenchymal transition believed to amplify tumor aggressiveness, suggesting that it may play a role in tumor progression. Acts as a regulator of chondrocyte differentiation, probably by regulating the expression of factors that control chondrocyte differentiation.
Clonality: Recombinant
Concentration: Lot dependent
NCBI: 4017
UniProt: Q9Y4K0
Buffer: Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Source: Synthetic peptide within Human LOXL2 aa 750 to the C-terminus
Target: LOXL2
Application Dilute: WB(1:300-5000)